Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Evan Yu
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
170 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Highlands Oncology Group-Rogers
Rogers, Arkansas, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Valley Medical Oncology Consultants
Pleasanton, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Tahoe Forest Cancer Center
Truckee, California, United States
- San Luis Valley Regional Medical Center
Alamosa, Colorado, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- the Shaw Regional Cancer Center
Edwards, Colorado, United States
- Front Range Cancer Specialists
Fort Collins, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Valley View Hospital Cancer Center
Glenwood Springs, Colorado, United States
- Saint Mary'S Hospital and Regional Medical Center
Grand Junction, Colorado, United States
- Montrose Memorial Hospital
Montrose, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Uf Cancer Center at Orlando Health
Orlando, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Kuakini Medical Center
Honolulu, Hawaii, United States
- Oncare Hawaii-Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii Inc-Pob Ii
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital
Honolulu, Hawaii, United States
- Tripler Army Medical Center
Honolulu, Hawaii, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Castle Medical Center
Kailua, Hawaii, United States
- Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue, Hawaii, United States
- Oncare Hawaii Inc-Pali Momi
‘Aiea, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Joseph Regional Medical Center
Lewiston, Idaho, United States
- Saint Anthony'S Health
Alton, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Heartland Cancer Research Ncorp
Decatur, Illinois, United States
- Hines Veterans Administration Hospital
Hines, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 30 Jun 2015
- Completion
- 23 Aug 2017
- Last update posted
- 26 Feb 2018
- Registered enrollment
- 211
- Registry id
- NCT01120236
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.